Correlation Between Lifecore Biomedical and Organogenesis Holdings
Can any of the company-specific risk be diversified away by investing in both Lifecore Biomedical and Organogenesis Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lifecore Biomedical and Organogenesis Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lifecore Biomedical and Organogenesis Holdings, you can compare the effects of market volatilities on Lifecore Biomedical and Organogenesis Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lifecore Biomedical with a short position of Organogenesis Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lifecore Biomedical and Organogenesis Holdings.
Diversification Opportunities for Lifecore Biomedical and Organogenesis Holdings
0.75 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Lifecore and Organogenesis is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding Lifecore Biomedical and Organogenesis Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Organogenesis Holdings and Lifecore Biomedical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lifecore Biomedical are associated (or correlated) with Organogenesis Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Organogenesis Holdings has no effect on the direction of Lifecore Biomedical i.e., Lifecore Biomedical and Organogenesis Holdings go up and down completely randomly.
Pair Corralation between Lifecore Biomedical and Organogenesis Holdings
Given the investment horizon of 90 days Lifecore Biomedical is expected to generate 1.2 times less return on investment than Organogenesis Holdings. But when comparing it to its historical volatility, Lifecore Biomedical is 1.65 times less risky than Organogenesis Holdings. It trades about 0.33 of its potential returns per unit of risk. Organogenesis Holdings is currently generating about 0.24 of returns per unit of risk over similar time horizon. If you would invest 295.00 in Organogenesis Holdings on August 28, 2024 and sell it today you would earn a total of 109.00 from holding Organogenesis Holdings or generate 36.95% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Lifecore Biomedical vs. Organogenesis Holdings
Performance |
| Timeline |
| Lifecore Biomedical |
| Organogenesis Holdings |
Lifecore Biomedical and Organogenesis Holdings Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Lifecore Biomedical and Organogenesis Holdings
The main advantage of trading using opposite Lifecore Biomedical and Organogenesis Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lifecore Biomedical position performs unexpectedly, Organogenesis Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Organogenesis Holdings will offset losses from the drop in Organogenesis Holdings' long position.| Lifecore Biomedical vs. Shuttle Pharmaceuticals | Lifecore Biomedical vs. Catalent | Lifecore Biomedical vs. Tilray Inc | Lifecore Biomedical vs. Kamada |
| Organogenesis Holdings vs. Shuttle Pharmaceuticals | Organogenesis Holdings vs. Lifecore Biomedical | Organogenesis Holdings vs. Redhill Biopharma | Organogenesis Holdings vs. Collegium Pharmaceutical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |